BioCentury
ARTICLE | Clinical News

Hemispherx regulatory update

April 29, 1996 7:00 AM UTC

HEMXU received six European patents covering the company's nucleic acid technologies. The patents, covered under the number EPO 88307529.3, cover a broad set of closely related nucleic acid compounds ...